Infertility — defined clinically as the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse — is one of the most emotionally devastating and socially consequential health conditions affecting Nigerian families.
In a cultural context where childbearing occupies a position of profound centrality in the definition of personal identity, marital success, family honour, and social belonging, the inability to conceive a child carries consequences that extend far beyond the biological — affecting psychological wellbeing, marital stability, social standing, and in many Nigerian communities, the very security of a woman's position within her husband's family and lineage.
The social weight attached to fertility in Nigerian culture — and particularly in the Igbo cultural tradition that predominates in South Eastern Nigeria — makes infertility not merely a medical problem requiring clinical intervention, but a life-defining crisis that millions of Nigerian couples navigate with inadequate medical support, insufficient information, and largely without access to the advanced reproductive technologies that have transformed infertility outcomes in developed countries.
Fertility care in Nigeria has a history that combines traditional remedies and herbalist consultations (which remain widely consulted even by educated urban couples seeking simultaneous modern medical care), conventional gynaecological and obstetric services, and a slowly emerging specialist reproductive medicine sector.
The first documented IVF birth in Nigeria occurred in 1989 at the University of Lagos Teaching Hospital (LUTH) — demonstrating that the technical capability for assisted reproductive technology has been present in Nigeria for over three decades. However, the diffusion of IVF capability from academic pioneer programmes to commercially accessible private clinics has been extremely slow compared to the trajectory of IVF adoption in South Africa, Kenya, Egypt, or indeed globally.
As of 2026, Nigeria has an estimated 80-120 registered IVF or fertility treatment centres across the country — an extraordinary undersupply for a nation of 228+ million people and an estimated 2-5 million couples affected by infertility at any given time.
South Eastern Nigeria — comprising the five states of Anambra, Enugu, Imo, Abia, and Ebonyi, with a combined population of approximately 37 million people — is one of the most critically underserved regions in Nigeria for specialist fertility care.
Despite the region's high per capita income relative to national averages (driven by substantial diaspora remittances from the United States, United Kingdom, and Canada), its large concentration of educated professional couples in the fertility-treatment-seeking age bracket, and its well-documented cultural premium on childbearing and fertility, the South East has fewer than 10 accredited or formally operated IVF-capable facilities — several of which are concentrated in Enugu city alone, leaving Anambra (home to the Onitsha commercial hub), Imo, Abia, and Ebonyi almost entirely without quality specialist fertility services.
The consequences of this infrastructure gap are measurable and humanly significant: couples who can afford treatment travel to Lagos (5-8 hour journey) or to Abuja (6-8 hour journey) to access the country's better-equipped IVF centres; couples who cannot afford travel or cannot manage extended absence from work and family obligations either delay treatment until their fertility window narrows further, or seek informal alternatives of uncertain efficacy; and couples with financial resources seek treatment internationally — in India, Dubai, the United Kingdom, or the United States — at total costs of NGN 3.5-25 million per treatment cycle (including travel) that are accessible only to the wealthiest South Eastern families, most of whom have direct diaspora connections.
Each of these paths represents a failure of the healthcare system to meet a profound human need that modern reproductive medicine is fully capable of addressing.
Chapter 1: Introduction and Executive Overview
1.1 Background to Fertility Care in Nigeria
1.2 Rising Infertility Rates and Demand for Assisted Reproductive Technology (ART)
1.3 Overview of IVF and Fertility Treatment Services
1.4 Purpose of the Investment Guide
1.5 Scope and Structure of the Report
1.6 Key Investment Highlights and Opportunity Summary
Chapter 2: Industry Overview and Market Landscape
2.1 Global Fertility and IVF Industry Overview
2.2 African Fertility Treatment Market Trends
2.3 Nigerian Fertility Care Industry Structure
2.4 Demand Drivers in South Eastern Nigeria
2.5 Socio-cultural Attitudes Toward Infertility and IVF
2.6 Market Gaps and Underserved Regions
2.7 Competitive Landscape and Existing IVF Centres in Nigeria
Chapter 3: Demand Analysis and Target Market
3.1 Demographic Profile of South Eastern Nigeria
3.2 Fertility Challenges and Prevalence Factors
3.3 Target Customer Segments
3.4 Medical Tourism Potential (Diaspora & West Africa)
3.5 Pricing Sensitivity and Affordability Analysis
3.6 Forecasted Demand for IVF Services (5-10 Year Outlook)
Chapter 4: Service Scope and Clinical Model
4.1 Core IVF and Fertility Services
4.2 Diagnostic and Laboratory Services
4.3 Obstetrics and Gynecology Support Services
4.4 Andrology and Male Fertility Services
4.5 Counselling, Psychological and Emotional Support Services
4.6 Value-Added Services (Genetic Testing, Surrogacy Advisory)
Chapter 5: Site Selection and Infrastructure Requirements
5.1 Criteria for Location Selection in South Eastern Nigeria
5.2 Recommended Cities (Enugu, Onitsha, Owerri, Aba)
5.3 Facility Design and Clinic Layout
5.4 IVF Laboratory Standards and Clean Room Requirements
5.5 Equipment Requirements and Technology Stack
5.6 Utility Needs (Power, Water, HVAC, Backup Systems)
5.7 Expansion and Scalability Considerations
Chapter 6: Regulatory, Legal and Ethical Framework
6.1 Regulatory Bodies in Nigeria (Medical and Fertility Care)
6.2 Licensing Requirements for IVF Clinics
6.3 Ethical Guidelines for Assisted Reproductive Technology
6.4 Patient Rights, Consent and Data Protection
6.5 Surrogacy and Donor Regulation Environment
6.6 Compliance Risks and Mitigation Strategies
Chapter 7: Operational Model and Human Resource Structure
7.1 Clinical Workflow and Patient Journey
7.2 Staffing Requirements and Organizational Structure
7.3 Training and Capacity Building
7.4 Quality Assurance and Success Rate Monitoring
7.5 Patient Experience Management System
7.6 Technology Integration (Electronic Medical Records, Lab Systems)
Chapter 8: Financial Feasibility and Investment Analysis
8.1 Capital Expenditure (Land, Buildings, Equipment)
8.2 Operating Costs (Salaries, Consumables, Utilities)
8.3 Revenue Streams and Pricing Models
8.4 Break-even Analysis and Payback Period
8.5 Profitability Projections (5-10 Years)
8.6 Sensitivity Analysis (Demand, Pricing, Currency Risks)
8.7 Funding Options and Investment Structures
Chapter 9: Risk Assessment and Mitigation Strategies
9.1 Clinical and Medical Risks
9.2 Regulatory and Legal Risks
9.3 Cultural and Social Acceptance Risks
9.4 Financial and Currency Risks
9.5 Operational and Technology Risks
9.6 Reputation and Trust Risks in Fertility Care
9.7 Risk Mitigation Framework
Chapter 10: Implementation Roadmap and Investment Conclusion
10.1 Phased Development Plan (Phase 1-3 Rollout Strategy)
10.2 Timeline for Project Execution
10.3 Strategic Partnerships (Hospitals, Diaspora Networks, Labs)
10.4 Marketing and Patient Acquisition Strategy
10.5 Long-Term Expansion Opportunities (West Africa Hub)
10.6 Final Investment Summary and Strategic Outlook
